Non-smokers’ lung cancer among top five global cancer-related deaths in 2023

The development of lung cancer in individuals who have never smoked.

Gilead, Cognizant expand deal to expedite digital transformation

The use of GenAI is intended to offer improved transparency about Gilead’s medicines to patients as well as internal staff. Credit: Sundry Photography / Shutterstock.com.

July 25, 2023

Novo Nordisk asks FDA to prohibit semaglutide compounding, following Eli Lilly

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 24, 2024

New sickle cell disease CRISPR treatments can’t make up for the shortage of adult hematologists

After decades of limited progress in the treatment of sickle cell disease (SCD), both patients and physicians are on the verge of monumental change. On

December 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.